LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 106 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.5%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $29,638,628 | 28.72% |
| Orland Properties Ltd | 15,093,969 | $22,188,134 | 11.75% |
| Foresite Capital Management IV, LLC | 8,784,813 | $12,913,675 | 7.17% |
| MIC Capital Management UK LLP | 1,740,569 | $2,558,636 | 0.58% |
| Alphabet Inc. | 5,865,125 | $8,621,733 | 0.55% |
| HSG Holding Ltd | 3,045,997 | $4,477,616 | 0.48% |
| Clarius Group, LLC | 399,168 | $586,777 | 0.06% |
| CAXTON ASSOCIATES LP | 198,477 | $291,761 | 0.04% |
| XTX Topco Ltd | 114,720 | $168,638 | 0.03% |
| BBR PARTNERS, LLC | 164,041 | $241,140 | 0.03% |
| Virtus ETF Advisers LLC | 28,661 | $42,132 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 97,126 | $142,775 | 0.03% |
| SHELL ASSET MANAGEMENT CO | 187,163 | $275 | 0.01% |
| PROFUND ADVISORS LLC | 73,442 | $107,960 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 34,540 | $51 | 0.00% |
| Rafferty Asset Management, LLC | 424,886 | $624,582 | 0.00% |
| AIGEN INVESTMENT MANAGEMENT, LP | 14,051 | $20,655 | 0.00% |
| China Universal Asset Management Co., Ltd. | 6,436 | $9 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 325,359 | $478,278 | 0.00% |
| EXCHANGE TRADED CONCEPTS, LLC | 61,920 | $91,022 | 0.00% |
External links
This page lists LYELL IMMUNOPHARMA INC's shareholders in Q3 2023. To view LYELL IMMUNOPHARMA INC's shareholder history, click here.